{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:52:42Z","timestamp":1775645562109,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001403","name":"Indian Institute of Technology Kanpur","doi-asserted-by":"publisher","award":["Intramural funds"],"award-info":[{"award-number":["Intramural funds"]}],"id":[{"id":"10.13039\/501100001403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05485-2","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:16:07Z","timestamp":1770110167000},"page":"1695-1711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination gene therapy with AAV based RPE65 and survivin vectors sustains phenotypic rescue in neural retina of LCA2 mice"],"prefix":"10.1007","volume":"481","author":[{"given":"Vijayata","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamshul","family":"Huda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Narendra Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giridhara R.","family":"Jayandharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"5485_CR1","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.3390\/ijms22137207","volume":"22","author":"M Aoun","year":"2021","unstructured":"Aoun M, Passerini I, Chiurazzi P, Karali M, De Rienzo I, Sartor G, Murro V, Filimonova N, Seri M, Banfi S (2021) Inherited retinal diseases due to RPE65 variants: from genetic diagnostic management to therapy. Int J Mol Sci 22:7207","journal-title":"Int J Mol Sci"},{"key":"5485_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/TACG.S230720","volume":"13","author":"SK Padhy","year":"2020","unstructured":"Padhy SK, Takkar B, Narayanan R, Venkatesh P, Jalali S (2020) Voretigene neparvovec and gene therapy for leber\u2019s congenital amaurosis: review of evidence to date. Appl Clin Genet 13:179\u2013208","journal-title":"Appl Clin Genet"},{"key":"5485_CR3","doi-asserted-by":"publisher","first-page":"13658","DOI":"10.1073\/pnas.0504167102","volume":"102","author":"TM Redmond","year":"2005","unstructured":"Redmond TM, Poliakov E, Yu S, Tsai J-Y, Lu Z, Gentleman S (2005) Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc Natl Acad Sci 102:13658\u201313663","journal-title":"Proc Natl Acad Sci"},{"key":"5485_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/archopht.117.3.399","volume":"117","author":"W Tulvatana","year":"1999","unstructured":"Tulvatana W, Adamian M, Berson EL, Dryja TP (1999) Photoreceptor rosettes in autosomal dominant retinitis pigmentosa with reduced penetrance. Arch Ophthalmol 117:399\u2013402","journal-title":"Arch Ophthalmol"},{"key":"5485_CR5","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1167\/iovs.11-7973","volume":"52","author":"VL Bonilha","year":"2011","unstructured":"Bonilha VL, Rayborn ME, Li Y, Grossman GH, Berson EL, Hollyfield JG (2011) Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase. Investig Ophthalmol Vis Sci 52:8381\u20138392","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5485_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/genes11010024","volume":"11","author":"FL Motta","year":"2019","unstructured":"Motta FL, Martin RP, Porto FB, Wohler ES, Resende RG, Gomes CP, Pesquero JB, Sallum JM (2019) Pathogenicity reclassification of RPE65 missense variants related to leber congenital amaurosis and early-onset retinal dystrophy. Genes 11:24","journal-title":"Genes"},{"key":"5485_CR7","volume-title":"GeneReviews\u00ae","author":"DL Chao","year":"2019","unstructured":"Chao DL, Burr A, Pennesi M (2019) RPE65-related leber congenital amaurosis\/early-onset severe retinal dystrophy. In: Adam MP, Ardinger HH, Pagon RA (eds) GeneReviews\u00ae. University of Washington Seattle, Seattle"},{"key":"5485_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.12998\/wjcc.v3.i2.112","volume":"3","author":"OF Chacon-Camacho","year":"2015","unstructured":"Chacon-Camacho OF, Zenteno JC (2015) Review and update on the molecular basis of leber congenital amaurosis. World J Clin Cases: WJCC 3:112","journal-title":"World J Clin Cases: WJCC"},{"key":"5485_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13816810.2014.991931","volume":"37","author":"S Katagiri","year":"2016","unstructured":"Katagiri S, Hayashi T, Kondo M, Tsukitome H, Yoshitake K, Akahori M, Ikeo K, Tsuneoka H, Iwata T (2016) RPE65 mutations in two Japanese families with leber congenital amaurosis. Ophthalmic Genet 37:161\u2013169","journal-title":"Ophthalmic Genet"},{"key":"5485_CR10","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JW Bainbridge","year":"2008","unstructured":"Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N (2008) Effect of gene therapy on visual function in leber\u2019s congenital amaurosis. N Engl J Med 358:2231\u20132239","journal-title":"N Engl J Med"},{"key":"5485_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/hum.2008.107","volume":"19","author":"WW Hauswirth","year":"2008","unstructured":"Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19:979\u2013990","journal-title":"Hum Gene Ther"},{"key":"5485_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/archopht.123.4.500","volume":"123","author":"G Le Meur","year":"2005","unstructured":"Le Meur G, Weber M, P\u00e9r\u00e9on Y, Mendes-Madeira A, Nivard D, Deschamps J-Y, Moullier P, Rolling F (2005) Postsurgical assessment and long-term safety of Recombinant adeno-associated virus\u2013mediated gene transfer into the retinas of dogs and primates. Arch Ophthalmol 123:500\u2013506","journal-title":"Arch Ophthalmol"},{"key":"5485_CR13","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM (2008) Safety and efficacy of gene transfer for leber\u2019s congenital amaurosis. N Engl J Med 358:2240\u20132248","journal-title":"N Engl J Med"},{"key":"5485_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/sj.gt.3302861","volume":"14","author":"G Le Meur","year":"2007","unstructured":"Le Meur G, Stieger K, Smith A, Weber M, Deschamps J-Y, Nivard D, Mendes-Madeira A, Provost N, Pereon Y, Cherel Y (2007) Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther 14:292\u2013303","journal-title":"Gene Ther"},{"key":"5485_CR15","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","volume":"372","author":"SG Jacobson","year":"2015","unstructured":"Jacobson SG, Cideciyan AV, Roman AJ, Sumaroka A, Schwartz SB, Heon E, Hauswirth WW (2015) Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med 372:1920\u20131926","journal-title":"N Engl J Med"},{"key":"5485_CR16","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","volume":"372","author":"JW Bainbridge","year":"2015","unstructured":"Bainbridge JW, Mehat MS, Sundaram V, Robbie SJ, Barker SE, Ripamonti C, Georgiadis A, Mowat FM, Beattie SG, Gardner PJ (2015) Long-term effect of gene therapy on leber\u2019s congenital amaurosis. N Engl J Med 372:1887\u20131897","journal-title":"N Engl J Med"},{"key":"5485_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13023-020-1304-1","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang X, Yu C, Tzekov RT, Zhu Y, Li W (2020) The effect of human gene therapy for RPE65-associated leber\u2019s congenital amaurosis on visual function: a systematic review and meta-analysis. Orphanet J Rare Dis 15:49","journal-title":"Orphanet J Rare Dis"},{"key":"5485_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","volume":"130","author":"SG Jacobson","year":"2012","unstructured":"Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A (2012) Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 130:9\u201324","journal-title":"Arch Ophthalmol"},{"key":"5485_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1089\/hum.2019.164","volume":"30","author":"S Maurya","year":"2019","unstructured":"Maurya S, Mary B, Jayandharan GR (2019) Rational engineering and preclinical evaluation of neddylation and sumoylation site modified adeno-associated virus vectors in murine models of hemophilia B and leber congenital amaurosis. Hum Gene Ther 30:1461\u20131476","journal-title":"Hum Gene Ther"},{"key":"5485_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","volume":"12","author":"H B\u00fcning","year":"2019","unstructured":"B\u00fcning H, Srivastava A (2019) Capsid modifications for targeting and improving the efficacy of AAV vectors. Mol Therapy Methods Clin Dev 12:248\u2013265","journal-title":"Mol Therapy Methods Clin Dev"},{"key":"5485_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/s41433-020-0838-8","volume":"34","author":"S Maurya","year":"2020","unstructured":"Maurya S, Mary B, Jayandharan GR (2020) Improved ocular gene transfer with a Neddylation-site modified AAV-RPE65 vector in rd12 mice. Eye 34:1313\u20131315","journal-title":"Eye"},{"key":"5485_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrm.2017.91","volume":"19","author":"G Hanson","year":"2018","unstructured":"Hanson G, Coller J (2018) Codon optimality, bias and usage in translation and mRNA decay. Nat Rev Mol Cell Biol 19:20\u201330","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5485_CR23","doi-asserted-by":"publisher","first-page":"E4940","DOI":"10.1073\/pnas.1719375115","volume":"115","author":"I Frumkin","year":"2018","unstructured":"Frumkin I, Lajoie MJ, Gregg CJ, Hornung G, Church GM, Pilpel Y (2018) Codon usage of highly expressed genes affects proteome-wide translation efficiency. Proc Natl Acad Sci USA 115:E4940\u2013E4949","journal-title":"Proc Natl Acad Sci USA"},{"key":"5485_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.gene.2019.05.008","volume":"707","author":"F Zarghampoor","year":"2019","unstructured":"Zarghampoor F, Azarpira N, Khatami SR, Behzad-Behbahani A, Foroughmand AM (2019) Improved translation efficiency of therapeutic mRNA. Gene 707:231\u2013238","journal-title":"Gene"},{"key":"5485_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mcn.2010.07.003","volume":"45","author":"N Habtemichael","year":"2010","unstructured":"Habtemichael N, Heinrich U-R, Knauer SK, Schmidtmann I, Bier C, Docter D, Brochhausen C, Helling K, Brieger J, Stauber RH (2010) Expression analysis suggests a potential cytoprotective role of Birc5 in the inner ear. Mol Cell Neurosci 45:297\u2013305","journal-title":"Mol Cell Neurosci"},{"key":"5485_CR26","doi-asserted-by":"publisher","first-page":"jcs223826","DOI":"10.1242\/jcs.223826","volume":"132","author":"SP Wheatley","year":"2019","unstructured":"Wheatley SP, Altieri DC (2019) Survivin at a glance. J Cell Sci 132:jcs223826","journal-title":"J Cell Sci"},{"key":"5485_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/labinvest.2013.103","volume":"93","author":"Y Terasaki","year":"2013","unstructured":"Terasaki Y, Terasaki M, Urushiyama H, Nagasaka S, Takahashi M, Kunugi S, Ishikawa A, Wakamatsu K, Kuwahara N, Miyake K (2013) Role of survivin in acute lung injury: epithelial cells of mice and humans. Lab Invest 93:1147\u20131163","journal-title":"Lab Invest"},{"key":"5485_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/jcp.21358","volume":"215","author":"MK Jones","year":"2008","unstructured":"Jones MK, Padilla OR, Webb NA, Norng M (2008) The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol\u2010induced injury via activation of the p34cdc2 cyclin\u2010dependent kinase. J Cell Physiol 215:750\u2013764","journal-title":"J Cell Physiol"},{"key":"5485_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0006-291X(02)02128-9","volume":"297","author":"M Deguchi","year":"2002","unstructured":"Deguchi M, Shiraki K, Inoue H, Okano H, Ito T, Yamanaka T, Sugimoto K, Sakai T, Ohmori S, Murata K (2002) Expression of survivin during liver regeneration. Biochem Biophys Res Commun 297:59\u201364","journal-title":"Biochem Biophys Res Commun"},{"key":"5485_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-9-2","volume":"9","author":"AN Alexopoulou","year":"2008","unstructured":"Alexopoulou AN, Couchman JR, Whiteford JR (2008) The CMV early enhancer\/chicken \u03b2 actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 9:1\u201311","journal-title":"BMC Cell Biol"},{"key":"5485_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/2211-5463.13029","volume":"11","author":"Y Dou","year":"2021","unstructured":"Dou Y, Lin Y, Wang T, Wang XY, Jia Yl (2021) Zhao cp: the CAG promoter maintains high-level transgene expression in HEK293 cells. FEBS Open Bio 11:95\u2013104","journal-title":"FEBS Open Bio"},{"key":"5485_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.plasmid.2014.06.003","volume":"74","author":"Y Liu","year":"2014","unstructured":"Liu Y, Fu S, Niu R, Yang C, Lin J (2014) Transcriptional activity assessment of three different promoters for mouse in utero electroporation system. Plasmid 74:52\u201358","journal-title":"Plasmid"},{"key":"5485_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/emm.2007.19","volume":"39","author":"Y Liu","year":"2007","unstructured":"Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K, Xiao S (2007) Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo. Exp Mol Med 39:170\u2013175","journal-title":"Exp Mol Med"},{"key":"5485_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00018-022-04161-0","volume":"79","author":"J Kajtna","year":"2022","unstructured":"Kajtna J, Tsang SH, Koch SF (2022) Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model. Cell Mol Life Sci 79:148","journal-title":"Cell Mol Life Sci"},{"key":"5485_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ymthe.2005.09.001","volume":"13","author":"J-j Pang","year":"2006","unstructured":"Pang J-j, Chang B, Kumar A, Nusinowitz S, Noorwez SM, Li J, Rani A, Foster TC, Chiodo VA, Doyle T (2006) Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 leber congenital amaurosis. Mol Ther 13:565\u2013572","journal-title":"Mol Ther"},{"key":"5485_CR36","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1073\/pnas.0500646102","volume":"102","author":"SG Jacobson","year":"2005","unstructured":"Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EA, Traboulsi EI, Heon E, Pittler SJ, Milam AH (2005) Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA 102:6177\u20136182","journal-title":"Proc Natl Acad Sci USA"},{"key":"5485_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.omtn.2022.11.021","volume":"31","author":"DH Jo","year":"2023","unstructured":"Jo DH, Jang H-K, Cho CS, Han JH, Ryu G, Jung Y, Bae S, Kim JH (2023) Visual function restoration in a mouse model of leber congenital amaurosis via therapeutic base editing. Mol Therapy Nucleic Acids 31:16\u201327","journal-title":"Mol Therapy Nucleic Acids"},{"key":"5485_CR38","doi-asserted-by":"publisher","first-page":"1291795","DOI":"10.3389\/fmed.2023.1291795","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu Y, Tai J, Yu C, Xu D, Xiao D, Pang J (2023) Unlocking therapeutic potential: dual gene therapy for ameliorating the disease phenotypes in a mouse model of RPE65 leber congenital amaurosis. Front Med 10:1291795","journal-title":"Front Med"},{"key":"5485_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/hum.2009.100","volume":"21","author":"GR Jayandharan","year":"2010","unstructured":"Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A (2010) Optimized Adeno-Associated virus (AAV)\u2013protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Hum Gene Ther 21:271\u2013283","journal-title":"Hum Gene Ther"},{"key":"5485_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10495-008-0180-2","volume":"13","author":"S Cottet","year":"2008","unstructured":"Cottet S, Schorderet DF (2008) Triggering of Bcl-2-related pathway is associated with apoptosis of photoreceptors in Rpe65-\/- mouse model of leber\u2019s congenital amaurosis. Apoptosis 13:329\u2013342","journal-title":"Apoptosis"},{"key":"5485_CR41","doi-asserted-by":"publisher","first-page":"e6616","DOI":"10.1371\/journal.pone.0006616","volume":"4","author":"S Hamann","year":"2009","unstructured":"Hamann S, Schorderet DF, Cottet S (2009) Bax-induced apoptosis in leber\u2019s congenital amaurosis: a dual role in rod and cone degeneration. PLoS ONE 4:e6616","journal-title":"PLoS ONE"},{"key":"5485_CR42","first-page":"6492034","volume":"2018","author":"S Assadiasl","year":"2018","unstructured":"Assadiasl S, Mousavi MJ, Amirzargar A (2018) Antiapoptotic molecule survivin in transplantation: helpful or harmful? J Transpl 2018:6492034","journal-title":"J Transpl"},{"key":"5485_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/10409238.2010.516740","volume":"45","author":"S Baratchi","year":"2010","unstructured":"Baratchi S, Kanwar RK, Kanwar JR (2010) Survivin: a target from brain cancer to neurodegenerative disease. Crit Rev Biochem Mol Biol 45:535\u2013554","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5485_CR44","doi-asserted-by":"publisher","first-page":"eaax1210","DOI":"10.1126\/sciadv.aax1210","volume":"5","author":"DH Jo","year":"2019","unstructured":"Jo DH, Song DW, Cho CS, Kim UG, Lee KJ, Lee K, Park SW, Kim D, Kim JH, Kim J-S (2019) CRISPR-Cas9\u2013mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of leber congenital amaurosis. Sci Adv 5:eaax1210","journal-title":"Sci Adv"},{"key":"5485_CR45","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","volume":"12","author":"GM Acland","year":"2005","unstructured":"Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072\u20131082","journal-title":"Mol Ther"},{"key":"5485_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ng0501-92","volume":"28","author":"GM Acland","year":"2001","unstructured":"Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM (2001) Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28:92\u201395","journal-title":"Nat Genet"},{"key":"5485_CR47","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.ymthe.2017.05.005","volume":"25","author":"MD Fischer","year":"2017","unstructured":"Fischer MD, McClements ME, de la Camara CM-F, Bellingrath J-S, Dauletbekov D, Ramsden SC, Hickey DG, Barnard AR, MacLaren RE (2017) Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa. Mol Ther 25:1854\u20131865","journal-title":"Mol Ther"},{"key":"5485_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/gt.2016.37","volume":"23","author":"X Hou","year":"2016","unstructured":"Hou X, Jiao R, Guo X, Wang T, Chen P, Wang D, Chen Y, He C, Chen Z (2016) Construction of minicircle DNA vectors capable of correcting Familial hypercholesterolemia phenotype in a LDLR-deficient mouse model. Gene Ther 23:657\u2013663","journal-title":"Gene Ther"},{"key":"5485_CR49","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/gt.2012.76","volume":"20","author":"JM Johnston","year":"2013","unstructured":"Johnston JM, Denning G, Doering CB, Spencer HT (2013) Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A. Gene Ther 20:607\u2013615","journal-title":"Gene Ther"},{"key":"5485_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41434-022-00380-z","volume":"30","author":"B Nieuwenhuis","year":"2023","unstructured":"Nieuwenhuis B, Laperrousaz E, Tribble JR, Verhaagen J, Fawcett JW, Martin KR, Williams PA, Osborne A (2023) Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene Ther 30:503\u2013519","journal-title":"Gene Ther"},{"key":"5485_CR51","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1089\/ten.tea.2013.0672","volume":"20","author":"SM Calado","year":"2014","unstructured":"Calado SM, Oliveira AV, Machado S, Haase R, Silva GA (2014) Sustained gene expression in the retina by improved episomal vectors. Tissue Eng Part A 20:2692\u20132698","journal-title":"Tissue Eng Part A"},{"key":"5485_CR52","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","volume":"13","author":"SG Jacobson","year":"2006","unstructured":"Jacobson SG, Acland GM, Aguirre GD, Aleman TS, Schwartz SB, Cideciyan AV, Zeiss CJ, Komaromy AM, Kaushal S, Roman AJ (2006) Safety of Recombinant adeno-associated virus type 2\u2013RPE65 vector delivered by ocular subretinal injection. Mol Ther 13:1074\u20131084","journal-title":"Mol Ther"},{"key":"5485_CR53","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu Z-F, Tillman A, Wittes J, Pappas J, Elci O, McCague S (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390:849\u2013860","journal-title":"Lancet"},{"key":"5485_CR54","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/sj.mt.6300389","volume":"16","author":"J Bennicelli","year":"2008","unstructured":"Bennicelli J, Wright JF, Komaromy A, Jacobs JB, Hauck B, Zelenaia O, Mingozzi F, Hui D, Chung D, Rex TS (2008) Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther 16:458\u2013465","journal-title":"Mol Ther"},{"key":"5485_CR55","doi-asserted-by":"publisher","first-page":"E517","DOI":"10.1073\/pnas.1218933110","volume":"110","author":"AV Cideciyan","year":"2013","unstructured":"Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, Iwabe S, Roman AJ, Olivares MB, Schwartz SB, Kom\u00e1romy AM (2013) Human retinal gene therapy for leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci USA 110:E517\u2013E525","journal-title":"Proc Natl Acad Sci USA"},{"key":"5485_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/biom14010122","volume":"14","author":"MD Fischer","year":"2024","unstructured":"Fischer MD, Simonelli F, Sahni J, Holz FG, Maier R, Fasser C, Suhner A, Stiehl DP, Chen B, Audo I (2024) Real-world safety and effectiveness of voretigene neparvovec: results up to 2 years from the prospective, registry-based PERCEIVE study. Biomolecules 14:122","journal-title":"Biomolecules"},{"key":"5485_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/humc.2017.125","volume":"28","author":"G-j Ye","year":"2017","unstructured":"Ye G-j, Komaromy AM, Zeiss C, Calcedo R, Harman CD, Koehl KL, Stewart GA, Iwabe S, Chiodo VA, Hauswirth WW (2017) Safety and efficacy of AAV5 vectors expressing human or canine CNGB3 in CNGB3-mutant dogs. Hum Gene Therapy Clin Dev 28:197\u2013207","journal-title":"Hum Gene Therapy Clin Dev"},{"key":"5485_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41434-022-00365-y","volume":"30","author":"IC Han","year":"2023","unstructured":"Han IC, Wiley LA, Ochoa D, Lang MJ, Harman BE, Sheehan KM, Mullins RF, Stone EM, Tucker BA (2023) Characterization of a novel Pde6b-deficient rat model of retinal degeneration and treatment with adeno-associated virus (AAV) gene therapy. Gene Ther 30:362\u2013368","journal-title":"Gene Ther"},{"key":"5485_CR59","first-page":"3846","volume":"63","author":"M Michaelides","year":"2022","unstructured":"Michaelides M, Xu J, Wang D, Wong P, Fung A, Forbes A, Naylor S, Zeldin R, Parker MA, Weleber R (2022) AAV5-RPGR (botaretigene sparoparvovec) gene therapy for X-linked retinitis pigmentosa (XLRP) demonstrates localized improvements in static perimetry. Investig Ophthalmol Vis Sci 63:3846\u20133846","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5485_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41434-020-0169-1","volume":"28","author":"B Nieuwenhuis","year":"2021","unstructured":"Nieuwenhuis B, Haenzi B, Hilton S, Carnicer-Lombarte A, Hobo B, Verhaagen J, Fawcett JW (2021) Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters. Gene Ther 28:56\u201374","journal-title":"Gene Ther"},{"key":"5485_CR61","doi-asserted-by":"publisher","first-page":"22541","DOI":"10.1038\/s41598-021-01818-x","volume":"11","author":"K Thirtamara Rajamani","year":"2021","unstructured":"Thirtamara Rajamani K, Leithead AB, Kim M, Barbier M, Peruggia M, Niblo K, Barteczko L, Lefevre A, Grinevich V, Harony-Nicolas H (2021) Efficiency of cell-type specific and generic promoters in transducing Oxytocin neurons and monitoring their neural activity during lactation. Sci Rep 11:22541","journal-title":"Sci Rep"},{"key":"5485_CR62","doi-asserted-by":"publisher","first-page":"e37197","DOI":"10.1371\/journal.pone.0037197","volume":"7","author":"J Yao","year":"2012","unstructured":"Yao J, Jia L, Khan N, Zheng Q-D, Moncrief A, Hauswirth WW, Thompson DA, Zacks DN (2012) Caspase Inhibition with XIAP as an adjunct to AAV vector gene-replacement therapy: improving efficacy and prolonging the treatment window. PLoS ONE 7:e37197","journal-title":"PLoS ONE"},{"key":"5485_CR63","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1006\/mthe.2001.0498","volume":"4","author":"LHM Sanftner","year":"2001","unstructured":"Sanftner LHM, Abel H, Hauswirth WW, Flannery JG (2001) Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a Transgenic rat model of retinitis pigmentosa. Mol Ther 4:622\u2013629","journal-title":"Mol Ther"},{"key":"5485_CR64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/cdd.2013.139","volume":"21","author":"D Westphal","year":"2014","unstructured":"Westphal D, Kluck RM, Dewson G (2014) Building blocks of the apoptotic pore: how Bax and bak are activated and oligomerize during apoptosis. Cell Death Differ 21:196\u2013205","journal-title":"Cell Death Differ"},{"key":"5485_CR65","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.3892\/mmr.2016.5830","volume":"14","author":"B Yue","year":"2016","unstructured":"Yue B, Lin Y, Ma X, Zhang G, Chen B (2016) Effect of survivin gene therapy via lentivirus vector on the course of intervertebral disc degeneration in an in vivo rabbit model. Mol Med Rep 14:4593\u20134598","journal-title":"Mol Med Rep"},{"key":"5485_CR66","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-3083.2007.01977.x","volume":"66","author":"M Bokarewa","year":"2007","unstructured":"Bokarewa M, Tarkowski A, Magnusson M (2007) Pathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritis. Scand J Immunol 66:192\u2013198","journal-title":"Scand J Immunol"},{"key":"5485_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2474-12-150","volume":"12","author":"P Lechler","year":"2011","unstructured":"Lechler P, Balakrishnan S, Schaumburger J, Gr\u00e4ssel S, Baier C, Grifka J, Straub RH, Renkawitz T (2011) The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro. BMC Musculoskelet Disord 12:1\u20138","journal-title":"BMC Musculoskelet Disord"},{"key":"5485_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-9-105","volume":"9","author":"N Liu","year":"2011","unstructured":"Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng R, Liu D, Lin F (2011) Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by survivin on experimental stroke in rats. J Translational Med 9:1\u201310","journal-title":"J Translational Med"},{"key":"5485_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/iovs.63.4.27","volume":"63","author":"R Usategui-Mart\u00edn","year":"2022","unstructured":"Usategui-Mart\u00edn R, Puertas-Neyra K, Galindo-Cabello N, Hern\u00e1ndez-Rodr\u00edguez LA, Gonz\u00e1lez-P\u00e9rez F, Rodr\u00edguez-Cabello JC, Gonz\u00e1lez-Sarmiento R, Pastor JC, Fernandez-Bueno I (2022) Retinal neuroprotective effect of mesenchymal stem cells secretome through modulation of oxidative stress, autophagy, and programmed cell death. Investig Ophthalmol Vis Sci 63:27\u201327","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5485_CR70","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1167\/iovs.09-4310","volume":"51","author":"H Levkovitch-Verbin","year":"2010","unstructured":"Levkovitch-Verbin H, Sadan O, Vander S, Rosner M, Barhum Y, Melamed E, Offen D, Melamed S (2010) Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Investig Ophthalmol Vis Sci 51:6394\u20136400","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5485_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-8-11","volume":"8","author":"I-H Pang","year":"2007","unstructured":"Pang I-H, Zeng H, Fleenor DL, Clark AF (2007) Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci 8:1\u201311","journal-title":"BMC Neurosci"},{"key":"5485_CR72","doi-asserted-by":"publisher","first-page":"e63749","DOI":"10.1371\/journal.pone.0063749","volume":"8","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Ko JH, Yun J-H, Kim J-A, Kim TE, Lee HJ, Kim SH, Park KH, Oh JY (2013) Stanniocalcin-1 protects retinal ganglion cells by inhibiting apoptosis and oxidative damage. PLoS ONE 8:e63749","journal-title":"PLoS ONE"},{"key":"5485_CR73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.omtn.2019.11.005","volume":"19","author":"M Karali","year":"2020","unstructured":"Karali M, Guadagnino I, Marrocco E, De Cegli R, Carissimo A, Pizzo M, Casarosa S, Conte I, Surace EM, Banfi S (2020) AAV-miR-204 protects from retinal degeneration by Attenuation of microglia activation and photoreceptor cell death. Mol Therapy-Nucleic Acids 19:144\u2013156","journal-title":"Mol Therapy-Nucleic Acids"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05485-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:02:57Z","timestamp":1775642577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05485-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["5485"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05485-2","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that IIT Kanpur has filed patent applications on AAV vectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments in the study were approved by the Institutional Animal Ethics Committee (IAEC) at Indian Institute of Technology, Kanpur, Uttar Pradesh.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}